Researchers conducted a multicenter, observational study of 884 hospitalized adult patients with Staphylococcus aureus bacteremia. They divided patients into three groups based on how long they had Staphylococcus aureus bacteremia:
● Short (one to two days)
● Intermediate (three to six days)
● Prolonged (seven of more days)
Of the 884 patients, 63 percent experienced a short duration of bacteremia; 28 percent experienced an intermediate duration; and 9 percent a prolonged duration.
The study shows the prolonged group had the highest proportion of methicillin-resistant Staphylococcus aureus. Choice of antibiotic therapy did not significantly affect bacteremia duration.
Researchers also found that metastatic complications, length of stay and 30-day mortality worsened as duration of having the bacteremia increased. Each day of bacteremia was associated with relative risk of death of 1.16.
More articles on healthcare quality:
Death of Louisiana nurse attacked by patient ruled a homicide
833 deaths linked to Congo’s Ebola outbreak: 4 updates
10 health systems hiring medical informatics leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.